Rejected at 8 a.m. Jul, 06, 2024 ] by Ahmed7
Author: Robozarp
Related Note: 1549586054765
Rationale for change

Changing the format as a T/F card does not effectively utilize active recall. It gives you the answer from the get-go asking to verify if it is true, which is more passive than having you actively recall the AE of raloxifene.
Source on estrogen agonist activity is from the extra section of this card.

Rejection reason

original is okay

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::Original_decks::Dorian::obgyn::ome::gyn::breast_cancer #AK_Step1_v12::#OME::Clinical::Surgery::General_Surgery::Breast_Cancer #AK_Step2_v12::!Shelf::ObGyn::no_dupes::only_step2 #AK_Step2_v12::Original_decks::Dorian::obgyn::hyfacts #AK_Step2_v12::#Resources_by_rotation::ObGyn::hyfacts #AK_Step2_v12::#B&B::04_Endocrinology::04_Other::04_Osteoporosis::Extra #AK_Step2_v12::#UWorld::COMLEX::28225 #AK_Step1_v12::#Bootcamp::Reproduction::06_Pharmacology::02_Selective_Estrogen_Receptor_Modulators #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::2obgyn !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::OBGYN::1-OME #AK_Step2_v12::#AMBOSS::Lq0w_S #AK_Step2_v12::!Shelf::ObGyn::no_dupes #AK_Step1_v12::#AMBOSS::_ka5qk #PANCE::EOR::Family_med #AK_Step1_v12::#UWorld::COMLEX::26013 #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#UWorld::Step::14920 #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::05_Sex_Hormones::01_SERMs_&_Aromatase_Inhibitors #AK_Step2_v12::#Resources_by_rotation::ObGyn::ome::gyn::breast_cancer #AK_Step2_v12::#UWorld::Step::2408 #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step3_v12::#UWorld::5517 #PANCE::EOR::IM #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Hypercoagulability::Deep_Vein_Thrombosis::Pathophysiology #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::23_Raloxifene_&_Tamoxifen #PANCE::CARDIO::vascular_disease